A laboratory study has found that the HER2 inhibitor lapatinib used to slow HER2-positive breast cancer can actually induce tumor growth in some circumstances.
Original Article: Lab Study Shows HER2 Inhibitor Lapatinib Can Induce Cell Proliferation